Erianin structure
|
Common Name | Erianin | ||
---|---|---|---|---|
CAS Number | 95041-90-0 | Molecular Weight | 318.364 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 439.1±40.0 °C at 760 mmHg | |
Molecular Formula | C18H22O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 219.4±27.3 °C |
Use of ErianinErianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis. |
Name | 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol |
---|---|
Synonym | More Synonyms |
Description | Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis. |
---|---|
Related Catalog | |
In Vitro | Erianin is often used as antipyretic and analgesic agent. Erianin belongs to bibenzyl derivatives in structure, with the activity of anti-virus, anti-bacterial, as well as anti-benign prostatic hyperplasia. Erianin has obvious damage on 2LL-IDO cells, Erianin basically has no cytotoxicity on human normal liver cell line L02, and cell viability is maintained at around 85%[1]. Erianin inhibits the growth of HeLa cells and induces apoptosis in a dose‑ and time‑dependent manner, inducing cell cycle arrest at the G2/M stage. Erianin treatment also increases the expression of Bax and caspase‑3, but decreases levels of Bcl‑2 and phosphorylated‑ERK1/2[2]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 439.1±40.0 °C at 760 mmHg |
Molecular Formula | C18H22O5 |
Molecular Weight | 318.364 |
Flash Point | 219.4±27.3 °C |
Exact Mass | 318.146729 |
PSA | 57.15000 |
LogP | 3.11 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.554 |
Phenol, 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]- |
Dihydrocombretatastin A-4 |
Erianin |
2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)-ethyl]-phenol |
5-(3,4,5-trimethoxyphenethyl)-2-methoxyphenol |
2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol |
(E)-2-methoxy-5-(3,4,5-trimethoxyphenylethyl)phenol |
3-hydroxy-3',4',4,5'-tetramethoxybibenzyl |
2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]benzolol |